Bio Green Med Solution/$BGMS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bio Green Med Solution
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.
Ticker
$BGMS
Sector
Primary listing
Employees
12
Headquarters
Kuala Lumpur, Malaysia
Website
BGMS Metrics
BasicAdvanced
$14M
-
-$4.06
0.09
-
Price and volume
Market cap
$14M
Beta
0.09
52-week high
$19.87
52-week low
$3.08
Average daily volume
161K
Financial strength
Current ratio
5.767
Quick ratio
5.625
Long term debt to equity
0.275
Total debt to equity
0.275
Profitability
EBITDA (TTM)
-10.355
Gross margin (TTM)
-580.00%
Net profit margin (TTM)
-64,080.00%
Operating margin (TTM)
-103,580.00%
Effective tax rate (TTM)
-18.19%
Management effectiveness
Return on assets (TTM)
-102.83%
Return on equity (TTM)
-276.80%
Valuation
Price to revenue (TTM)
1,008.237
Price to book
2.78
Price to tangible book (TTM)
2.78
Price to free cash flow (TTM)
-1.15
Free cash flow yield (TTM)
-86.96%
Free cash flow per share (TTM)
-5.535
Growth
Revenue change (TTM)
-87.50%
10-year revenue growth (CAGR)
-40.47%
BGMS News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Bio Green Med Solution stock?
Bio Green Med Solution (BGMS) has a market cap of $14M as of September 12, 2025.
What is the P/E ratio for Bio Green Med Solution stock?
The price to earnings (P/E) ratio for Bio Green Med Solution (BGMS) stock is 0 as of September 12, 2025.
Does Bio Green Med Solution stock pay dividends?
No, Bio Green Med Solution (BGMS) stock does not pay dividends to its shareholders as of September 12, 2025.
When is the next Bio Green Med Solution dividend payment date?
Bio Green Med Solution (BGMS) stock does not pay dividends to its shareholders.
What is the beta indicator for Bio Green Med Solution?
Bio Green Med Solution (BGMS) has a beta rating of 0.09. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.